BIZ NEWS: Is Sarepta Therapeutics a Good Gene Therapy Stock to Buy Now? - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Tuesday, 26 March 2019

BIZ NEWS: Is Sarepta Therapeutics a Good Gene Therapy Stock to Buy Now?


Is Sarepta Therapeutics a Good Gene Therapy Stock to Buy Now?



It's hard not to get excited about this company's experimental gene therapy for Duchenne muscular dystrophy.

via FOX BUSINESS NEWS https://ift.tt/2HYSqTM

No comments:

Post a Comment

Post Top Ad